Probuphine buprenorphine: Additional Phase III data

Additional data from a U.S. Phase III trial in 287 patients aged 18-60 with opioid dependence showed that 36% of patients treated with Probuphine had negative urine samples

Read the full 288 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE